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Essay
C
ourts in the United States 
have historically judged 
execution methods against 
“evolving standards of decency,” and 
have prohibited punishments that 
involve “the unnecessary and wanton 
inﬂiction of pain,” or more recently the 
“substantial risk of serious harm” [1]. 
Public repugnance and legal challenges 
to execution by cyanide gas and 
electrocution led to the development 
of lethal injection as an ostensibly 
more humane method of state killing 
[2,3]. The intravenous delivery of an 
anesthetic, a paralytic, and potassium 
chloride in lethal injection protocols 
is intended to cause a painless death, 
which likely accounts for its use in 930 
of the 1,100 executions in the United 
States from the re-establishment of the 
death penalty in 1976 to May 6, 2008, 
as well as for its growing use worldwide 
[4,5].
Despite the procedure’s use of drugs 
and medical personnel and equipment, 
lethal injection for execution was 
conceived and implemented by 
physicians and corrections personnel 
without adherence to standards 
now used for developing and testing 
new clinical procedures. Oklahoma 
legislators looking for a more humane 
and less expensive alternative to the 
electric chair approached the state 
medical examiner, Jay Chapman, 
who suggested a protocol that was 
subsequently approved by the chairman 
of anesthesiology at the University of 
Oklahoma and then written into law 
[2,3,5]. Chapman has since stated 
that he did no research in choosing 
the drugs [5]. Moreover, there is no 
evidence of any directed experimental 
or clinical research of this protocol 
being performed prior to the ﬁrst lethal 
injection, the 1982 Texas execution 
of Charlie Brooks. Subsequently, 
execution data and eyewitness reports 
from various states indicate that some 
inmates have suffered during lethal 
injection, and suggest that others may 
have suffered without detection [6–8]. 
Such observations have prompted 
legal challenges as well as judicially 
mandated or executive review of states’ 
protocols [9].
Lethal Injection Investigative 
Activities
Execution records are unavailable 
from many jurisdictions, including 
Texas and Virginia, which together 
have performed 51.1% of lethal 
injection executions [4]. However, 
evidence obtained in litigation and 
from Freedom of Information Act 
requests reveals that at least some 
jurisdictions systematically collect data 
on executions and outcomes (Table 1). 
The motivations for the data collections 
are largely unknown, although in 
certain cases, the processes suggest a 
prospective intent to collect data, e.g., 
assaying thiopental levels in virtually 
all executed inmates, while in others 
the stated goal is to assess adequacy 
of anesthesia in life and post-mortem 
thiopental changes after death [6]. 
Moreover, the collection of multiple, 
timed post-mortem blood samples from 
individual inmates in Connecticut and 
North Carolina was clearly intended to 
address questions regarding thiopental 
redistribution [10]. 
In addition to data collection 
activities, systematic modiﬁcations 
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Summary 
Lethal injection for execution has 
largely replaced other execution 
methods, in part due to the appearance 
of a peaceful death; however, available 
evidence indicates that some inmates 
actually suffer extreme pain. This has 
triggered legal challenges against 
lethal injection on the grounds that it 
violates the United States’ constitutional 
prohibition against cruel and unusual 
punishment. Some jurisdictions collect 
comprehensive data on executions and 
outcomes, and some have modiﬁed their 
lethal injection protocols. Recently, jurists 
and lethal injection advisory panels have 
recommended speciﬁc changes to be 
instituted for future executions. Such 
use of biomedical inquiry to evaluate, 
modify, and “improve” protocols 
resembles human experimentation and 
should be scrutinized against accepted 
norms for ethical conduct of research, 
particularly given the vulnerable nature 
of the prisoner population. Although 
the regulations governing prisoner 
research vary by jurisdiction, the ethical 
framework for the modiﬁcation of lethal 
injection protocols should be made clear 
prior to further investigation into how to 
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of lethal injection protocols have 
been implemented or are planned in 
several jurisdictions, with the effect 
of subjecting inmates to different 
drug doses or injection sequences 
(Table 1). In certain cases, such as 
the use of at least three different 
chemical paralytics in Oklahoma or 
three different doses of thiopental in 
Texas, the impetus for change from 
the standard protocol is unknown. 
For others, including rearranging 
the drug injection sequence in North 
Carolina and increasing the dose of 
thiopental in Florida, expert testimony, 
judicial orders, or recommendations 
from special state panels were involved 
[8,11–14]. In these latter cases, the 
jurisdictions were responding directly 
to charges that the prior process of 
lethal injection posed an unacceptable 
risk of pain and suffering. 
Many of the methods being used 
to collect data in executions and 
modify lethal injection protocols 
incorporate biomedical research 
activities. Moreover, processes such as 
prospective blood and vitreous sample 
collections, thiopental or potassium 
assays, bispectral index monitoring 
with the intent to gauge consciousness 
in execution, and the systematic 
alteration of drugs, doses, and order 
of drug administration in various 
groups of inmates are invasive activities 
that carry substantial implications for 
prisoners. This raises the concern: 
are corrections ofﬁcials and judges 
engaging in human experimentation 
as they seek to improve lethal injection 
protocols? 
Guidelines for Ethical Conduct of 
Human Subjects Research
Modern policies, including guidelines 
and regulations for the ethical 
conduct of research involving human 
subjects, such as the Nuremberg 
Code, the World Medical Association’s 
Declaration of Helsinki, the Council for 
International Organizations of Medical 
Sciences, and the Belmont Report, 
were developed at least partially in 
response to experimentation on 
prisoner populations. Together they 
describe a set of rules designed to 
guide researchers and reviewers 
in order to protect the interests of 
research participants. In the US, 
federally funded research is regulated 
by the Federal Policy for the Protection 
of Human Subjects (also known as the 
“Common Rule”) [15]. The Common 
Rule provides protection for research 
participants by requiring institutional 
assurance of compliance with federal 
regulations, institutional review 
board (IRB) review, approval, and 
oversight, and informed consent of the 
participants. Currently the Common 
Rule categorizes prisoner subjects as 
a vulnerable population requiring 
special protections. Although the 
Common Rule strictly applies only to 
research conducted or supported by 
federal departments or agencies, many 
states, universities, hospitals, and other 
private enterprises apply its standards 
uniformly across all research projects, 
regardless of funding source, and the 
Common Rule is generally considered 
an important standard for ethical 
conduct of human experimentation in 
the United States.
Table 1. Known Lethal Injection Investigative Activities by Jurisdiction
States Activities
Arizona, Georgia, and South Carolina •  Assayed thiopental in post-mortem blood samples from many or all executed inmates [6].
California •  Medical personnel completed detailed execution logs of heart and respiration rates and times at which respiration, 
heart-beat, and electrocardiogram rhythm ceased in all 11 lethal injections since 1996 [33].
•  Collected data were reviewed by attorneys, the presiding judge, and corrections ofﬁcials in litigation [33,34].
•  The judge ordered protocol modiﬁcations, suggesting elimination of the paralytic, or of both the paralytic and 
potassium chloride in favor of 5 g thiopental only [34].
•  The corrections department proposed changes including switching from 5 g to 3 g in two bolus injections [16,33].
Connecticut and Montana •  Assayed serum thiopental in samples from multiple sites and at multiple time-points after death to address 
adequacy of anesthesia in life and redistribution of thiopental after death [10].
Florida •  Increased thiopental from 2.5 g to 5 g [35].
North Carolina •  Practiced at least three versions of lethal injection since its ﬁrst use of thiopental and pancuronium only in 1984. 
In 1998, potassium chloride was added and the injection order rearranged. After criticism from an expert witness, 
the injection order was changed to the current protocol of serial, bilateral injections of thiopental, pancuronium 
bromide, and potassium chloride [2] [36–38].
•  Assayed thiopental in nearly all of its executed inmates; most recently collected multiple samples from different 
sites and time-points to address adequacy of anesthesia in life and thiopental distribution after death [6].
•  Attorneys, the presiding judge, and corrections ofﬁcials reviewed collected data in litigation [36–38].
•  Responding to a judicial order to assure anesthesia, ofﬁcials employed a bispectral index monitor, although the 
physician present monitored neither the inmate nor the device [39–42].
Oklahoma •  According to autopsy reports: In the 3-drug protocol, used tubocurarine from January 6, 2000 to January 31, 2002, 
when they switched to succinylcholine. From April 3, 2003 to August 24, 2004, they used vecuronium bromide. 
•  Assayed thiopental levels in post-mortem blood samples collected within minutes to hours after execution. This 
activity was referred to as an “ongoing analysis” [43].
•  Assayed vitreous potassium levels.
•  The Oklahoma Supreme Court explicitly countenanced an ongoing prospective collection of data and modiﬁcation: 
“We again express our conﬁdence that the Department of Corrections will continue to monitor and revise the 
execution protocol as may be necessary to ensure a swift, painless and humane execution” [44].
Texas •  Changed from 3 g thiopental in 30 ml to 3 g in 120 ml. For an unknown period, Texas used 2 g thiopental [45] .
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The Common Rule deﬁnes 
research as “a systematic investigation, 
including research development, 
testing and evaluation, designed to 
develop or contribute to generalizable 
knowledge”—without explicitly 
deﬁning “generalizable knowledge.” 
A human subject is a “living individual 
about whom an investigator….obtains 
(1) Data through intervention or 
interaction with the individual, or 
(2) Identiﬁable private information.” 
Intervention includes both physical 
procedures by which data are 
generated and manipulations of the 
subject or environment performed for 
research purposes. While the Common 
Rule is often applied to biomedical 
research, it covers the range of human 
experimentation, including education 
and behavioral studies as well as 
medical device or drug studies with no 
beneﬁcial intent.
Lethal Injection Investigations as 
Human Subjects Research
The evidence displayed in Table 1 
indicates that the collective practice of 
lethal injection has employed invasive 
testing of different drug protocols and 
devices, data collection and monitoring, 
and systematic review with outcome data 
being used to revise practice. Therefore, 
it might be argued that certain lethal 
injection inquiries constitute human 
subjects research as deﬁned in the 
Common Rule. Corrections ofﬁcials 
and their medical collaborators might 
contend that their intent is not to 
produce “generalizable knowledge”, i.e., 
information for use in other settings, but 
rather to improve the protocol within 
a particular jurisdiction. It is important 
to keep in mind, however, that virtually 
all US lethal injection protocols derive 
directly from the initial Oklahoma 
legislation and Texas experience as 
communicated by corrections ofﬁcials 
[2]. A former executioner for Virginia 
and Georgia has stated that he both 
assisted Florida with its electrocution 
protocol and visited Texas to observe 
that state’s lethal injection protocol 
prior to the ﬁrst Virginia lethal 
injection. More recently, the State of 
California cited surveys and site visits 
to other jurisdictions as “invaluable” in 
making improvements in that state’s 
lethal injection protocol [16]. In 
addition, the Department of Justice has 
held at least one execution training 
session, for corrections personnel from 
Arizona, California, Florida, Missouri, 
and Tennessee. Although there have 
been only three lethal injections 
under Federal jurisdiction, the session 
included protocol overviews, facility 
tours, discussion of current issues, 
practical exercises, and networking [17]. 
Given this history, it is conceivable that 
protocol modiﬁcations resulting from 
activities performed in particular states 
would likely be communicated to or 
copied by other jurisdictions, in effect 
generalizing the conclusions to others.
On the contrary, some might argue 
that the evaluation and modiﬁcation 
of lethal injection protocols has been 
practiced solely to “improve” lethal 
injection within jurisdictions and not to 
contribute to generalizable knowledge, 
thereby inviting comparison to clinical 
quality improvement projects. Such 
a designation falls short of “human 
subjects research” and its current 
federal regulatory requirements. 
Although presently there is a lack of 
consensus regarding the deﬁnition 
of quality improvement in health 
care and the requirements for 
its ethical oversight, the Hastings 
Center convened a group to address 
the ethical requirements of quality 
improvement and their relationship 
to regulations protecting human 
subjects of research. In a recently 
published report, the group deﬁned 
quality improvement as “systematic, 
data-guided activities designed to bring 
about immediate improvements,” that 
“at its heart is a form of experiential 
learning that regards improvement to 
be part of the work process and always 
involves deliberate actions expected to 
improve care, guided by data reﬂecting 
the effects” [18,19]. They conclude that 
while quality improvement activities 
may differ from human subjects 
research, they are not exempt from 
ethical requirements, including social 
or scientiﬁc value, scientiﬁc validity, fair 
participant selection, favorable risk–
beneﬁt ratios, respect for participants, 
informed consent, and independent 
review. Thus in this interpretation, 
classifying lethal injection investigations 
as quality improvement activities 
would not exempt such studies from 
some type of ethical oversight, even if 
they do not fall within the purview of 
traditional IRBs.
If lethal injection data collection 
and modiﬁcation activities meet the 
deﬁnition of research or human 
experimentation, a substantial set of 
policies become relevant. Collectively, 
internationally accepted standards 
for the ethical conduct of research 
demand that properly conducted 
human studies:
•  be founded upon adequate scientiﬁc 
data and animal experimentation, 
•  be conducted by scientiﬁcally 
qualiﬁed persons, 
•  be reviewed and supervised by a 
qualiﬁed review board, 
•  be performed with the consent of the 
participants, and 
•  must minimize risk to human subjects.
Judging lethal injection data 
collection and protocol modiﬁcation 
activities by these standards reveals 
fundamental ﬂaws. First, none of the 
current protocols were ever tested in 
animals; indeed, details of dose and 
administration actually contradict 
current veterinary practices [2,5,8]. 
Thus neither the original protocol nor 
subsequent modiﬁcations are “founded 
upon adequate scientiﬁc data and 
adequate animal experimentation.” 
Second, the scientiﬁc and medical 
qualiﬁcations of those responsible 
for evaluating and modifying lethal 
injection protocols (distinct from 
those participating in executions) vary 
from state to state, but are known to 
range from lay volunteers or prison 
staff with no medical training to judges 
and medical experts advising in the 
courtroom but not present in the 
execution chamber [3,20–22]. 
Third, lethal injection research 
activities have not been subject 
to expert review. The only known 
reviews of lethal injection protocols 
have been retrospective reviews by 
sometimes secret executive committees 
convened by governors in California, 
Tennessee, and Florida [16,23,24]. 
However, those reviews were focused 
speciﬁcally upon investigating past 
execution outcomes, rewriting 
outdated protocol handbooks, and 
facilitating future executions, but not 
upon explicitly protecting the interests 
of the prisoners being executed, which 
is the intent of guidelines such as 
the Common Rule [16,24]. Fourth, 
consent for these activities has not been 
described. Under all accepted ethical 
guidelines, including the Common 
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must be free and not subjected to 
undue inﬂuence or coercion. Finally, 
while some lethal injection studies 
could be considered minimal or no 
risk (electrocardiogram monitoring, 
post-mortem sample collection) others, 
including the addition or omission of 
drugs and altering of drug doses and 
sequences, seem to present substantial 
risk. Indeed, the risk of extreme pain 
and suffering is at the heart of the 
current lethal injection debate.
Additional Protections for Prisoner 
Subjects of Research
Finally, prisoners constitute a 
vulnerable group that historically has 
been provided special protections 
in research in large part because of 
concerns regarding the difﬁculty of 
ensuring voluntary informed consent in 
this setting. Under current regulations, 
death row inmates have the same 
protections as other prisoners; while 
they may have been stripped of the 
right to freedom and to life, they 
maintain the right to bodily integrity 
and to refuse participation in research 
[25]. Subpart C of the Common Rule 
speciﬁes additional protections for 
prisoner subjects and limits research to 
minimal risk studies relating directly to 
incarceration; research on conditions 
particular to prisoners as a class (but 
only with approval by the Secretary 
of Health and Human Services); and 
research that has the “intent and 
reasonable probability of improving the 
health or well-being of the subject.” The 
Common Rule explicitly prohibits all 
other biomedical and behavioral studies 
on prisoners. In its 2006 report, “Ethical 
Considerations for Research Involving 
Prisoners,” the Institute of Medicine 
recommended changes to the Common 
Rule, including (1) expanding the 
deﬁnition of research, (2) ensuring 
universal, consistent ethical protection, 
(3) shifting from categorical to 
risk–beneﬁt-based research review, (4) 
employing collaborative responsibility, 
and (5) enhancing systematic 
oversight—although these have not yet 
been employed [26]. 
State Regulation of Prisoner 
Research and Implications for 
Lethal Injection
We have been evaluating lethal 
injection investigation against the 
Common Rule, but as recognized by 
the Institute of Medicine, the Common 
Rule regulates only a fraction of 
human experimentation conducted 
in the United States. In the absence 
of federal authority, state laws, when 
they exist, become the only regulatory 
paradigm [27]. Further, when state 
laws exist and afford additional 
protections for research subjects they 
are to be followed [28]. Virtually 
all lethal injections and thus lethal 
injection investigative activities occur 
in state prisons, where regulation 
of human subjects research and 
prisoner protections vary considerably. 
Arizona allows any research approved 
by the prison director and chief of 
inmate health services, while Georgia 
merely requires research approval 
by the commissioner of corrections 
[29]. Oregon law states that “there 
shall be no medical, psychiatric, or 
psychological experimentation or 
research with inmates in Department 
of Corrections institutions of the State 
of Oregon,” although it limits the ban 
to “nontherapeutic” procedures [30]. 
California law prohibits all “biomedical 
research” except for participation 
in investigational new drug research 
deemed in the best medical interest 
of the inmate [31]. In Virginia, 
“nontherapeutic research using 
institutionalized participants shall be 
prohibited unless it…will not present 
greater than minimal risk” [32]. 
Overall, 30 states require IRB review 
of prison research studies; therapeutic 
biomedical research is permissible in 15 
of 48 state departments of correction, 
while only three states permit 
biomedical studies of a nontherapeutic 
nature [26]. Thus, because both lethal 
injection protocols and regulatory 
authority of individual jurisdictions vary 
signiﬁcantly, the legal requirements of 
such studies ultimately must be decided 
upon a case-by-case basis. To our 
knowledge, however, there has been no 
attempt to apply regulatory standards 
for human experimentation or IRB 
review and oversight to lethal injection 
activities to date.
Conclusions
While lethal injection and the death 
penalty present a host of ethical 
questions, the speciﬁc, pressing issue 
now faced by 36 US states, the federal 
government, and the 3,350 prisoners 
on death row is the movement to 
amend lethal injection protocols to 
comport with Eighth Amendment 
requirements and to minimize the 
potential for pain and suffering, in 
itself a commendable goal. As jurists 
demand lethal injection protocol 
changes, however, corrections 
ofﬁcials, governors, and their medical 
collaborators are left in a legal and 
ethical quandary. In order to comply 
with the law and carry out their 
duties, they are employing the tools 
and methods of biomedical inquiry 
without its ethical safeguards. Given 
the current guidelines for human 
experimentation, it is difﬁcult to 
conceive of circumstances in which 
lethal injection research activities could 
be carried out in a fashion consistent 
with these ethical norms, and yet those 
engaged in such research would seem 
to be required to do so. We submit 
that the ethical framework, if any, for 
the modiﬁcation of lethal injection 
protocols must be made clear prior 
to further investigation into how to 
“improve the process.”  
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